Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
Nhz7VLeA2QWc1q3M